AMD and Retinal Disease Perspective

 
 
  • Should We Treat or Observe DME With Good Vision? Treating all patients with central-involved diabetic macular edema, regardless of their vision quality, may not be a clinically effective strategy.
  • ADA 2020 Read clinically focused news coverage of key developments from ADA 2020
  • Novel Anti-VEGF Delivery System Aims to Reshape AMD Treatment Early results highlight the promise of a permanent, refillable port implant, which allows sustained delivery of ranibizumab.
  • AI for Eyes Is 'Nothing Short of Remarkable'   Pearse Keane joins Eric Topol and Abraham Verghese on this episode of Medicine and the Machine to discuss the unique opportunities for AI and deep learning in ophthalmology.
  • ARVO 2020 Read clinically focused news coverage of key developments from ARVO 2020
  • COVID and Med Ed: Resident and Student Describe 'New Normal' The COVID-19 pandemic has also changed life for med students and residents who aren't on the front lines. Two siblings--one a student, the other a resident--discuss what they have experienced.
  • Hydroxychloroquine: Possible COVID Drug Can Be Toxic to Retinas Before it was a potential COVID-19 therapy, it was a well-studied treatment with an established risk for retinal toxicity.
  • The Week That Wasn't: Cancer in Space, AI Predicts Intelligence, Curing Blindness Three medical stories that we didn't cover, explained.
  • A Breakthrough Year in Retina Research Dr Charles Wykoff highlights the many innovations in retina research in 2019, from the milestone moment of gene therapy to the diagnostic promise of artificial intelligence.
  • AAO 2019 Read clinically focused news coverage of key developments from AAO 2019
  • EASD 2019 Read clinically focused news coverage of key developments from EASD 2019
  • Is Treat-and-Extend Truly Effective for Diabetic Macular Edema? A 2-year study is the latest to highlight this approach's benefits, but its design also overlooks an important comparative treatment.
  • Protocol V Sheds Light on Managing Mild Diabetic Macular Edema Until now, data have been relatively scarce on the optimal treatment timing for patients who have diabetic macular edema with good vision.
  • ACC Empowers Cardiologists to Use Diabetes Drugs for Heart Disease   The ACC Expert Consensus Pathway puts cardiologists on track to use novel diabetes drugs to prevent heart failure in high-risk patients, says Dr Anne Peters.
  • Why Myopia Matters: 5 Things to Know Half of the world's population is projected to be myopic by 2050. Here are two facts to know about this common cause of impaired vision, along with three strategies to respond to its rising incidence.
  • ASRS 2019 Read clinically focused news coverage of key developments from ASRS 2019
  • A 50-Year-Old Man With Optic Disc Edema A 50-year-old man was noted to have optic disc edema and visual field defects in each eye. What is the most likely cause?
  • What's the Mediterranean Diet's Value in AMD? A recent pooled analysis makes a compelling case for this diet's protective role, but establishing a direct causal role remains elusive.
  • FLUID Study Rethinks Treat-and-Extend in Neovascular AMD Study results show that some subretinal fluid can be tolerated after anti-VEGF injections without sacrificing visual outcomes. Dr Charles Wykoff explains why it may not be that simple.
  • ADA 2019 Read clinically focused news coverage of key developments from ADA 2019